深部局部肺高温症对COVID-19癌症患者的影响
Mohammadbagher Tavakoli1, Reza Moghareabed2, Hossein Taheri1
1Department of Medical Physics, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Advanced biomedical research
|December 24, 2024
概括
深度局部高热显著改善了COVID-19癌症患者的氧和,并减少了感染的肺体积. 这种治疗也对D-二聚合物水平产生了积极的影响,表明其作为有效疗法的潜力.
科学领域:
- 在瘤学瘤学.
- 肺部病理学 肺部病理学
- 传染性疾病 传染性疾病
背景情况:
- 2019年新冠病毒病 (COVID-19) 对癌症患者构成重大风险.
- 在免疫功能低下的人群中评估COVID-19的新型治疗干预措施至关重要.
研究的目的:
- 为了评估深度局部高温症在癌症患者的COVID-19管理中的有效性.
- 为了确定高热症对氧和和肺部感染严重性的影响.
主要方法:
- 50名COVID-19癌症患者被分为两组:标准护理 (I组) 和高温治疗 (II组).
- 计算机断层扫描 (CT) 扫描评估了感染的肺部体积,同时在三天内监测了氧和度 (SpO2) 和D-二元水平.
- 对II组进行了深度局部高温治疗.
主要成果:
- 第二组在高温后的SpO2从85%增加到91.3%,相比之下,第一组的SpO2从85%增加到88%.
- 在II组 (31.36至4.0) 与I组 (34.21至10.0) 相比,受感染的肺体积大幅下降.
- 在II组 (3200到510) 中,D-二聚合物水平的降低比I组 (3100到740) 更有效.
结论:
- 深度局部高温症对SpO2产生积极影响,并在COVID-19癌症患者中减少感染的肺体积.
- 该疗法还导致D-二聚合物,C-反应蛋白和乳酸脱酶的减少,支持其潜在的临床实用性.
相关概念视频
02:49Cancer Therapies
7.4K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.4K
01:17Other Pulmonary Disorders
778
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
778
01:25Increased Body Temperature
611
A body temperature above 38°C (100.4 °F) is known as fever or pyrexia, and a person with fever is termed 'febrile.' Typically, the hypothalamus, a part of the brain that acts as the body's thermostat, regulates body temperature through a thermoregulatory setpoint. It receives signals from cold and warm thermal receptors throughout the body and adjusts the body's temperature accordingly. Fever occurs when this hypothalamic setpoint is altered, usually in...
611
01:29Decreased Body Temperature
573
A decreased body temperature can occur in patients with hypothermia and frostbite. Heat loss with extended cold exposure overpowers the body's ability to create heat, resulting in hypothermia. Core temperature readings help classify hypothermia. Mild hypothermia is temperatures between 32 °C (89.6 °F) and 35°C (95 °F) and is caused by impaired thermoregulation. Moderate hypothermia is temperatures between 28 C (82.4 °F) and 32 °C (89.6 °F) caused by...
573
01:20COPD: Pathogenesis and Clinical Features
168
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
168
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.6K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.6K